Acute hypoxia simultaneously induces the expression of gp91phox and endothelial nitric oxide synthase in the porcine pulmonary artery

Thorax

Volumn 60, Issue 4, 2005, Pages 305-313

  Muzaffar, S ^b   Shukla, N ^b   Angelini, G D ^b   Jeremy, J Y ^a,b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; APOCYNIN; CYTOKINE; DIPHENYLIODONIUM SALT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTOXIN; ENZYME INHIBITOR; GLYCOPROTEIN GP 91; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; CYBB PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; OXYGEN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME REGULATION; HYPOXIA; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; REOXYGENATION; SPECTROPHOTOMETRY; SWINE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; ANOXIA; CELL CULTURE; IMMUNOHISTOCHEMISTRY; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; ANOXIA; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; OXYGEN; PULMONARY ARTERY; SUPEROXIDES; SWINE;

EID: 16844377787     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.018796     Document Type: Article

References (48)

1. Chow C-W, Abreu MTH, Suzuki T, et al. Oxidative stress and lung injury. Am J Respir Cell Mol Biol 2003;29:427-31.
2. Chabot F, Mitchell JA, Gutteridge JMC, et al. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11:745-57.
3. Weinacker AB, Vaszar LT. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 2001;52:221-37.
4. Folkerts G, Kloek J, Muijsers RB, et al. Reactive nitrogen and oxygen species in airway inflammation. Eur J Pharmacol 2001;429:251-62.
5. Stuart-Smith K, Jeremy JY. Microvessel damage in acute respiratory distress syndrome: the answer may not be NO. Br J Anaesth 2001;87:272-9.
6. Davidson CA, Kaminski PM, Wolin MS. NO elicits prolonged relaxation of bovine pulmonary arteries via endogenous peroxynitrite generation. Am J Physiol 1997;273:L437-44.
7. Beckman JS. Peroxynitrite: rebounding from nitric oxide. Circ Res 2001;89:295-7.
8. Jeremy JY, Rowe D, Emsley AM, et al. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 1999;43:580-94.
9. Jeremy JY, Shukla N, Muzaffar S, et al. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol 2004;2:229-36.
10. Muzaffar S, Jeremy JY, Angelini GD, et al. The role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries. Thorax 2003;58:598-604.
11. 2α and cytokines. Br J Pharmacol 2004;141:488-96.
12. phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation 2004;110:1140-7.
13. Jernigan NL, Resta TC, Walker BR. Contribution of oxygen radicals to altered NO-dependent pulmonary vasodilation in acute and chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2004;286:L947-55.
14. Liu JQ, Sham JS, Shimoda LA, et al. Hypoxic constriction and reactive oxygen species in porcine distal pulmonary arteries. Am J Physiol 2003;285:L322-3.
15. Raj U, Shimoda L. Oxygen-dependent signaling in pulmonary vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002;283:L671-7.
16. Terada LS, Guidot DM, Leff JA, et al. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 1992;89:3362-6.
17. Dawson TL, Gores GJ, Nieminen AL, et al. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol 1993;264:C961-7.
18. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
19. Liesching T, Kwok H, Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest 2003;124:699-713.
20. Li C, Jackson RM. Reactive species: mechanisms of cellular hypoxia-reoxygenotion injury. Am J Physiol 2002;282:C227-41.
21. Le QT, Denko NC, Giaccia AJ. Hypoxic gene expression and metastasis. Cancer Metast Rev 2004;23:293-310.
22. Verhoeven AJ, Bolscher BG, Meerhof LJ, et al. Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood 1989;73:1686-94.
23. Nims RW, Cook JC, Krishna MC. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 1996;268:93-105.
24. Herget J, Wilhelm J, Novotna J, et al. A possible role of the oxidant tissue injury in the development of hypoxic pulmonary hypertension. Physiol Res 2000;49:493-501.
25. Marshall C, Mamary AJ, Verhoeven AJ. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol 1996;15:633-44.
26. 2? Am J Physiol Lung Cell Mol Physiol 2000;279:L683-90.
27. Kaminski PM, Wolin MS. Hypoxia increases superoxide anion production from bovine coronary microvessels, but not cardiac myocytes, via increased xanthine oxidase. Microcirculation 1994;1:231-6.
28. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001;52:159-64.
29. Dempsey EC, Frid MG, Aldashev AA, et al. Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: importance of protein kinase C. Can J Physiol Pharmacol 1997;75:936-44.
30. Weissmann N, Voswinckel R, Hardebusch T, et al. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am J Physiol 1999;276:L90-5.
31. Hoffmann A, Gloe T, Pohl U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J Cell Physiol 2001;188:33-44.
32. Darley-Usmar V, Halliwell B. Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996;13:649-61.
33. Steudel W, Scherrer-Crosbie M, Bloch KD, et al. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 1998;101:2468-77.
34. Fagan KA, Fouty BW, Tyler RC, et al. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 1999;103:291-9.
35. O'Connor M, Salzman AL, Szabo C. Role of peroxynitrite in the protein oxidation and apoptotic DNA fragmentation in vascular smooth muscle cells stimulated with bacterial lipopolysaccharide and interferon-gamma. Shock 1997;8:439-43.
36. Zouki C, Zhang SL, Chan JS, et al. Peroxynitrite induces integrin-dependent adhesion of human neutrophils to endothelial cells via activation of the Raf-1/MEK/Erk pathway. FASEB J 2001;15:25-7.
37. Zou MH, Ullrich V. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett 1996;382:101-4.
38. Macmillan-Crow L, Crow J, Kerby J, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996;93:11853-8.
39. Klinger JR. Inhaled nitric oxide in ARDS. Crit Care Clin 2002;18:45-68.
40. Wang T, El Kebir D, Blaise G. Inhaled nitric oxide in 2003: a review of its mechanisms of action. Can J Anaesth 2003;50:839-46.
41. Weinberger B, Laskin DL, Heck DE, et al. The toxicology of inhaled nitric oxide. Toxicol Sci 2001;59:5-16.
42. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study at the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
43. Irukayama-Tomobe Y, Sakai S, Miyauchi T. Chronic treatment with probucol effectively inhibits progression of pulmonary hypertension in rats. Life Sci 2000;67:2017-23.
44. Nathens AB, Neff MJ, Jurkavich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002;236:814-22.
45. Baboolal HA, Ichinose F, Ullrich R, et al. Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice. Anesthesiology 2002;97:1227-33
46. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-9.
47. Steinhorn RH, Albert G, Swartz DD, et al. Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am J Respir Crit Care Med 2001;164:834-9.
48. Pacht ER, DeMichele SJ, Nelson JL, et al. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003;31:491-500.